<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02701296</url>
  </required_header>
  <id_info>
    <org_study_id>11-10-004</org_study_id>
    <nct_id>NCT02701296</nct_id>
  </id_info>
  <brief_title>Posterior Capsular Injection With Femoral Nerve Block for Total Knee Arthroplasty</brief_title>
  <official_title>Assessment of Knee Pain in Patients Receiving Continuous Femoral Nerve Block Combined With Either Ultrasound Guided Posterior Capsular Injection or Selective Tibial Nerve Block Following Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Saint Francis Care</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Saint Francis Care</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess pain control after total knee replacement surgery using two different nerve block
      techniques. The 2 methods are:

        1. Continuous femoral nerve block with ultrasound guided posterior capsular injection

        2. Continuous femoral nerve block with ultrasound selective tibial nerve block.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients undergoing total knee replacement surgery experience severe post-operative pain.
      Continuous femoral nerve block combined with selective tibial nerve block provides optimal
      pain control in the anterior and posterior aspect of the knee respectively. However, in
      patients with pre-existing neuropathy of the sciatic nerve, the blockade of tibial nerve is
      contraindicated because of increased risk of nerve damage that may lead to exacerbation of
      neurologic symptoms. In such patients where selective tibial nerve block cannot be offered,
      ultrasound guided posterior knee capsular injection may be an alternative technique for
      controlling posterior knee pain after surgery. Posterior capsular injection by surgeons
      intraoperatively, when combined with femoral nerve block has been shown to provide pain
      control after total knee replacement. With posterior capsular injection, the main trunk of
      the tibial nerve is spared and only the terminal nerve endings innervating the posterior knee
      joint is blocked providing effective pain control. In this study, the efficacy of ultrasound
      guided posterior capsular injections performed pre-operatively will be compared to tibial
      nerve block in controlling knee pain after surgery.

      The results of this study may help establish the efficacy of ultrasound guided posterior
      capsular injection as an alternative to tibial nerve block in patients undergoing total knee
      arthroplasty.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 7, 2011</start_date>
  <completion_date type="Actual">August 31, 2014</completion_date>
  <primary_completion_date type="Actual">August 31, 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Intensity</measure>
    <time_frame>48 hours post surgery</time_frame>
    <description>Mean Numeric Pain Rating Scale (NPRS) self-reported pain Intensity on a 11-point score (0=no pain to 10= worst possible) in Post Anesthesia Care Unit (PACU) and every 6 hours for 48 hours post surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Opioid Consumption</measure>
    <time_frame>24 hours post surgery</time_frame>
    <description>Amount of opioid used for the first 24 hours post surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plantar Flexion in the Tibial Nerve Distribution</measure>
    <time_frame>Upon emergence from anesthesia in the PACU</time_frame>
    <description>Blinded nurse assessment on a 3-point scale 0= normal (No Motor Block), 1= weak (Partial Motor Block), 2 = absent (Complete Motor Block)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cold Sensation in the Tibial Nerve Distribution</measure>
    <time_frame>Upon emergence from anesthesia in the PACU</time_frame>
    <description>Number of participants with a self reported on a 3-point scale; 0=normal (No Sensory Block), 1= absent cold perception but touch sensation in tact (Partial Sensory Block), 2= absence of touch sensation (Complete Sensory Block)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dorsiflexion in the Peroneal Nerve Distribution</measure>
    <time_frame>Upon emergence from anesthesia in the PACU</time_frame>
    <description>Number of participants with a blinded nurse assessment on a 3-point scale 0= normal (No Motor Block), 1= weak (Partial Motor Block), 2 = absent (Complete Motor Block)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensation in the Peroneal Nerve Distribution</measure>
    <time_frame>Upon emergence from anesthesia in the PACU</time_frame>
    <description>Number of participants with self reported on a 3-point scale; 0=normal (No Sensory Block), 1= absent cold perception but touch sensation in tact (Partial Sensory Block), 2= absence of touch sensation (Complete Sensory Block)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Posterior Knee Infiltration</condition>
  <arm_group>
    <arm_group_label>Posterior capsular injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ultrasound guided posterior capsular injection of ropivacaine with epinephrine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tibial nerve block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ultrasound selective tibial nerve block of ropivacaine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine with Epinephrine</intervention_name>
    <description>Posterior capsular injection - ultrasound guided infiltration of Ropivacaine with Epinephrine between popliteal artery and capsule of knee above the femoral condyles</description>
    <arm_group_label>Posterior capsular injection</arm_group_label>
    <other_name>Naropin</other_name>
    <other_name>Adrenalin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>Tibial nerve block - ultrasound selective Ropivacaine tibial nerve block in the popliteal fossa</description>
    <arm_group_label>Tibial nerve block</arm_group_label>
    <other_name>Naropin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients having primary, unilateral total knee arthroplasty

          -  Age 18-80

        Exclusion Criteria:

          -  History of neurologic disease, neuropathy, diabetes, or major systemic illness

          -  Allergy to local anesthetic solution or NSAIDs

          -  Pregnancy

          -  Chronic use of narcotics

          -  Inability to give consent/cooperate with study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sanjay Sinha</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saint Francis Hospital and Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Saint Francis Hospital and Medical Center</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>February 17, 2016</study_first_submitted>
  <study_first_submitted_qc>March 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 8, 2016</study_first_posted>
  <results_first_submitted>May 19, 2017</results_first_submitted>
  <results_first_submitted_qc>May 19, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">June 14, 2017</results_first_posted>
  <last_update_submitted>October 2, 2018</last_update_submitted>
  <last_update_submitted_qc>October 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Infiltration between popliteal artery and capsule of knee (iPACK)</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Posterior Capsular Injection</title>
          <description>Ultrasound guided posterior capsular injection of ropivacaine with epinephrine
Ropivacaine with Epinephrine: Posterior capsular injection - ultrasound guided infiltration of Ropivacaine with Epinephrine between popliteal artery and capsule of knee above the femoral condyles</description>
        </group>
        <group group_id="P2">
          <title>Tibial Nerve Block</title>
          <description>Ultrasound selective tibial nerve block of ropivacaine
Ropivacaine: Tibial nerve block - ultrasound selective Ropivacaine tibial nerve block in the popliteal fossa</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
                <participants group_id="P2" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
                <participants group_id="P2" count="36">Data was incomplete for two participants their data was not included in the overall data analysis.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Incomplete Data</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Posterior Capsular Injection</title>
          <description>Ultrasound guided posterior capsular injection of ropivacaine with epinephrine
Ropivacaine with Epinephrine: Posterior capsular injection - ultrasound guided infiltration of Ropivacaine with Epinephrine between popliteal artery and capsule of knee above the femoral condyles</description>
        </group>
        <group group_id="B2">
          <title>Tibial Nerve Block</title>
          <description>Ultrasound selective tibial nerve block of ropivacaine
Ropivacaine: Tibial nerve block - ultrasound selective Ropivacaine tibial nerve block in the popliteal fossa</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="42"/>
            <count group_id="B2" value="36"/>
            <count group_id="B3" value="78"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65.9" spread="8.0"/>
                    <measurement group_id="B2" value="63.5" spread="8.9"/>
                    <measurement group_id="B3" value="64.8" spread="8.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="43"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="36"/>
                    <measurement group_id="B3" value="78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Pain Intensity</title>
        <description>Mean Numeric Pain Rating Scale (NPRS) self-reported pain Intensity on a 11-point score (0=no pain to 10= worst possible) in Post Anesthesia Care Unit (PACU) and every 6 hours for 48 hours post surgery</description>
        <time_frame>48 hours post surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Posterior Capsular Injection</title>
            <description>Ultrasound guided posterior capsular injection of ropivacaine with epinephrine
Ropivacaine with Epinephrine: Posterior capsular injection - ultrasound guided infiltration of Ropivacaine with Epinephrine between popliteal artery and capsule of knee above the femoral condyles</description>
          </group>
          <group group_id="O2">
            <title>Tibial Nerve Block</title>
            <description>Ultrasound selective tibial nerve block of ropivacaine
Ropivacaine: Tibial nerve block - ultrasound selective Ropivacaine tibial nerve block in the popliteal fossa</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Intensity</title>
          <description>Mean Numeric Pain Rating Scale (NPRS) self-reported pain Intensity on a 11-point score (0=no pain to 10= worst possible) in Post Anesthesia Care Unit (PACU) and every 6 hours for 48 hours post surgery</description>
          <units>pain score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>PACU Admission</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5" spread="2.95"/>
                    <measurement group_id="O2" value="3.2" spread="3.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PACU Discharge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" spread="1.78"/>
                    <measurement group_id="O2" value="1.5" spread="1.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6th hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" spread="1.85"/>
                    <measurement group_id="O2" value="2.0" spread="2.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12th hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0" spread="2.36"/>
                    <measurement group_id="O2" value="1.2" spread="2.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18th hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.3" spread="2.21"/>
                    <measurement group_id="O2" value="3.2" spread="2.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24th hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.7" spread="2.21"/>
                    <measurement group_id="O2" value="3.4" spread="2.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30th hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.6" spread="2.40"/>
                    <measurement group_id="O2" value="3.0" spread="2.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>36th hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.5" spread="2.46"/>
                    <measurement group_id="O2" value="2.7" spread="2.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>42nd hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2" spread="1.82"/>
                    <measurement group_id="O2" value="3.2" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48th hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.5" spread="1.98"/>
                    <measurement group_id="O2" value="3.4" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Opioid Consumption</title>
        <description>Amount of opioid used for the first 24 hours post surgery</description>
        <time_frame>24 hours post surgery</time_frame>
        <population>Mean consumption of Hydromorphone(mg) post-op day 1</population>
        <group_list>
          <group group_id="O1">
            <title>Posterior Capsular Injection</title>
            <description>Ultrasound guided posterior capsular injection of ropivacaine with epinephrine
Ropivacaine with Epinephrine: Posterior capsular injection - ultrasound guided infiltration of Ropivacaine with Epinephrine between popliteal artery and capsule of knee above the femoral condyles</description>
          </group>
          <group group_id="O2">
            <title>Tibial Nerve Block</title>
            <description>Ultrasound selective tibial nerve block of ropivacaine
Ropivacaine: Tibial nerve block - ultrasound selective Ropivacaine tibial nerve block in the popliteal fossa</description>
          </group>
        </group_list>
        <measure>
          <title>Opioid Consumption</title>
          <description>Amount of opioid used for the first 24 hours post surgery</description>
          <population>Mean consumption of Hydromorphone(mg) post-op day 1</population>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.33" spread="0.655"/>
                    <measurement group_id="O2" value="0.42" spread="0.706"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Plantar Flexion in the Tibial Nerve Distribution</title>
        <description>Blinded nurse assessment on a 3-point scale 0= normal (No Motor Block), 1= weak (Partial Motor Block), 2 = absent (Complete Motor Block)</description>
        <time_frame>Upon emergence from anesthesia in the PACU</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Posterior Capsular Injection</title>
            <description>Ultrasound guided posterior capsular injection of ropivacaine with epinephrine
Ropivacaine with Epinephrine: Posterior capsular injection - ultrasound guided infiltration of Ropivacaine with Epinephrine between popliteal artery and capsule of knee above the femoral condyles</description>
          </group>
          <group group_id="O2">
            <title>Tibial Nerve Block</title>
            <description>Ultrasound selective tibial nerve block of ropivacaine
Ropivacaine: Tibial nerve block - ultrasound selective Ropivacaine tibial nerve block in the popliteal fossa</description>
          </group>
        </group_list>
        <measure>
          <title>Plantar Flexion in the Tibial Nerve Distribution</title>
          <description>Blinded nurse assessment on a 3-point scale 0= normal (No Motor Block), 1= weak (Partial Motor Block), 2 = absent (Complete Motor Block)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Complete Motor Block</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Partial Motor Block</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No Motor Block</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                    <measurement group_id="O2" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cold Sensation in the Tibial Nerve Distribution</title>
        <description>Number of participants with a self reported on a 3-point scale; 0=normal (No Sensory Block), 1= absent cold perception but touch sensation in tact (Partial Sensory Block), 2= absence of touch sensation (Complete Sensory Block)</description>
        <time_frame>Upon emergence from anesthesia in the PACU</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Posterior Capsular Injection</title>
            <description>Ultrasound guided posterior capsular injection of ropivacaine with epinephrine
Ropivacaine with Epinephrine: Posterior capsular injection - ultrasound guided infiltration of Ropivacaine with Epinephrine between popliteal artery and capsule of knee above the femoral condyles</description>
          </group>
          <group group_id="O2">
            <title>Tibial Nerve Block</title>
            <description>Ultrasound selective tibial nerve block of ropivacaine
Ropivacaine: Tibial nerve block - ultrasound selective Ropivacaine tibial nerve block in the popliteal fossa</description>
          </group>
        </group_list>
        <measure>
          <title>Cold Sensation in the Tibial Nerve Distribution</title>
          <description>Number of participants with a self reported on a 3-point scale; 0=normal (No Sensory Block), 1= absent cold perception but touch sensation in tact (Partial Sensory Block), 2= absence of touch sensation (Complete Sensory Block)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Complete Sensory Block</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Partial Sensory Block</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No Sensory Block</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Dorsiflexion in the Peroneal Nerve Distribution</title>
        <description>Number of participants with a blinded nurse assessment on a 3-point scale 0= normal (No Motor Block), 1= weak (Partial Motor Block), 2 = absent (Complete Motor Block)</description>
        <time_frame>Upon emergence from anesthesia in the PACU</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Posterior Capsular Injection</title>
            <description>Ultrasound guided posterior capsular injection of ropivacaine with epinephrine
Ropivacaine with Epinephrine: Posterior capsular injection - ultrasound guided infiltration of Ropivacaine with Epinephrine between popliteal artery and capsule of knee above the femoral condyles</description>
          </group>
          <group group_id="O2">
            <title>Tibial Nerve Block</title>
            <description>Ultrasound selective tibial nerve block of ropivacaine
Ropivacaine: Tibial nerve block - ultrasound selective Ropivacaine tibial nerve block in the popliteal fossa</description>
          </group>
        </group_list>
        <measure>
          <title>Dorsiflexion in the Peroneal Nerve Distribution</title>
          <description>Number of participants with a blinded nurse assessment on a 3-point scale 0= normal (No Motor Block), 1= weak (Partial Motor Block), 2 = absent (Complete Motor Block)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Complete Motor Block</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Partial Motor Block</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No Motor Block</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41"/>
                    <measurement group_id="O2" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sensation in the Peroneal Nerve Distribution</title>
        <description>Number of participants with self reported on a 3-point scale; 0=normal (No Sensory Block), 1= absent cold perception but touch sensation in tact (Partial Sensory Block), 2= absence of touch sensation (Complete Sensory Block)</description>
        <time_frame>Upon emergence from anesthesia in the PACU</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Posterior Capsular Injection</title>
            <description>Ultrasound guided posterior capsular injection of ropivacaine with epinephrine
Ropivacaine with Epinephrine: Posterior capsular injection - ultrasound guided infiltration of Ropivacaine with Epinephrine between popliteal artery and capsule of knee above the femoral condyles</description>
          </group>
          <group group_id="O2">
            <title>Tibial Nerve Block</title>
            <description>Ultrasound selective tibial nerve block of ropivacaine
Ropivacaine: Tibial nerve block - ultrasound selective Ropivacaine tibial nerve block in the popliteal fossa</description>
          </group>
        </group_list>
        <measure>
          <title>Sensation in the Peroneal Nerve Distribution</title>
          <description>Number of participants with self reported on a 3-point scale; 0=normal (No Sensory Block), 1= absent cold perception but touch sensation in tact (Partial Sensory Block), 2= absence of touch sensation (Complete Sensory Block)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Complete Sensory Block</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Partial Sensory Block</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No Sensory Block</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37"/>
                    <measurement group_id="O2" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>24 hours after total knee replacement surgery</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Posterior Capsular Injection</title>
          <description>Ultrasound guided posterior capsular injection of ropivacaine with epinephrine
Ropivacaine with Epinephrine: Posterior capsular injection - ultrasound guided infiltration of Ropivacaine with Epinephrine between popliteal artery and capsule of knee above the femoral condyles</description>
        </group>
        <group group_id="E2">
          <title>Tibial Nerve Block</title>
          <description>Ultrasound selective tibial nerve block of ropivacaine
Ropivacaine: Tibial nerve block - ultrasound selective Ropivacaine tibial nerve block in the popliteal fossa</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="36"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="36"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="36"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Sanjay Sinha, MD</name_or_title>
      <organization>ST. FRANCIS HOSPITAL AND MEDICAL CENTER</organization>
      <email>sanjaysinha@comcast.net</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

